-
In this paper Pappone and his colleagues report a randomized study comparing circumferential pulmonary vein ablation (CPVA) to antiarrhythmic drug therapy in patients with paroxysmal atrial fibrillation who had previously failed at least one trial with antiarrhythmic drugs.
-
Several important papers have been published in the last 2 months, none more important than the realization that breast cancer rates have dropped precipitously since the publication of the Women's Health Initiative (WHI) in 2002.
-
-
For defibrillation success there is no significant difference between monophasic and biphasic shocks.
-
Significant reductions in door-to-balloon time for acute STEMI are accomplished by reducing the time required to activate the cardiac catherization lab.
-
Patients with coronary artery disease who have received intra-coronary, drug-eluding stents (DES) may benefit from longer courses of clopidogrel than is currently standard.
-
Bivalirudin has been shown to provide equivalent outcomes, but less bleeding in patients undergoing elective percutaneous coronary interventions (PCI).
-
The amount of myocardial scar on MRI predicts the clinical response to cardiac resynchronization.
-
The same appearances in presentation of men and women with ACS can largely be explained by factors other than sex.
-
In the Framingham study non-HDL cholesterol is a stonger predictor of subsequent CHD than LDL cholesterol.
